![]() | Only 14 pages are availabe for public view |
Abstract ABSTRACT Background; Dialysis patients experience an excess mortality, predominantly of sudden cardiac death (SCD). Vitamin D deficiency is present in the vast majority of patients with chronic kidney disease (CKD), and correcting a poor vitamin D status is recommended as a treatment of CKD–mineral and bone disorders. Accumulating evidence suggests a role of vitamin D for myocardial and overall health. Aim and objectives: The aim of this study is to assess the correlation between active vitamin D analogues supplementation and cardiovascular outcomes in prevalent hemodialysis patients. Subjects and methods: This was prospective interventional study, conducted Abo elnomros hemodialysis unit, on 50 prevalent HD patients. All patients were subjected to the following: Demographic data, laboratory investigations during the last 6 months, Echo-cardiogram before the study and after 6 months. Result: The mean Ca was 7.94(±0.77 SD), the mean Po4 was 4.8(±0.8 SD), the mean PTH was 381(±127 SD), the mean vitamin D was 11.4(±1.5 SD). Conclusion: High prevalence of vit D deficiency in dialysis patients, and showed a significant association between 25‐OH vitamin D analogues supplementation and decrease cardio-vascular risk |